Robert M.  Hershberg net worth and biography

Robert Hershberg Biography and Net Worth

CEO, President & Chair of HilleVax

Rob Hershberg, M.D., Ph.D., is President, Chief Executive Officer and chairman of the board of directors of HilleVax. Rob is a Venture Partner with Frazier Healthcare Partners and has been working with Frazier and its portfolio companies as an Entrepreneur-in-Residence, Senior Advisor, and executive for 14 years. He was formerly President and Chief Executive Officer of VentiRx Pharmaceuticals, a Frazier-founded company developing a small molecule therapeutic to activate the immune system against solid tumors. Rob cofounded VentiRx while an entrepreneur-in-residence at Frazier and led the company through its transformational partnership with Celgene. He joined Celgene in 2014 to lead their efforts in Immuno-Oncology, was promoted to Executive Vice President and Chief Scientific Officer in 2016 and was subsequently Executive Vice President and Head of Business Development & Global Alliances and served as a member of the Executive Committee until the acquisition of Celgene by Bristol-Myers Squibb in 2019.

Prior to VentiRx, Rob served as Senior Vice President and Chief Medical Officer of Dendreon Corporation and led clinical development of Provenge, which was approved for metastatic prostate cancer. Before Dendreon, he was Vice President of Medical Genetics at Corixa, a Frazier portfolio company which was acquired by GlaxoSmithKline. Earlier, Rob was an Assistant Professor at Harvard Medical School and an Associate Physician at Brigham and Women’s Hospital in Boston.

Rob completed his undergraduate and medical degrees at the University of California, Los Angeles and received his Ph.D. at the Salk Institute for Biological Studies.

How old is Robert M. Hershberg?

Dr. Hershberg is currently 62 years old. There are 5 older executives and no younger executives at HilleVax. Learn More on Robert M. Hershberg's age.

How do I contact Robert M. Hershberg?

The corporate mailing address for Dr. Hershberg and other HilleVax executives is , , . HilleVax can also be reached via phone at 617-213-5054 and via email at [email protected]. Learn More on Robert M. Hershberg's contact information.

Has Robert M. Hershberg been buying or selling shares of HilleVax?

Robert M. Hershberg has not been actively trading shares of HilleVax during the last quarter. Learn More on Robert M. Hershberg's trading history.

Who are HilleVax's active insiders?

HilleVax's insider roster includes Robert Hershberg (CEO, President & Chair), Aditya Kohli (COO & Director ), and David Socks (CFO & Chief Bus. Officer ). Learn More on HilleVax's active insiders.

Are insiders buying or selling shares of HilleVax?

During the last twelve months, insiders at the sold shares 15 times. They sold a total of 111,039 shares worth more than $986,935,022.27. The most recent insider tranaction occured on March, 20th when Director Aditya Kohli sold 6,000 shares worth more than $985,326,000.00. Insiders at HilleVax own 29.3% of the company. Learn More about insider trades at HilleVax.

Information on this page was last updated on 3/20/2024.

Robert M. Hershberg Insider Trading History at HilleVax

See Full Table

Robert M. Hershberg Buying and Selling Activity at HilleVax

This chart shows Dr. Robert M. Hershberg's buying and selling at HilleVax by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

HilleVax Company Overview

HilleVax logo
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $16.63
Low: $15.56
High: $17.23

50 Day Range

MA: $16.22
Low: $14.15
High: $19.75

2 Week Range

Now: $16.63
Low: $9.94
High: $20.22

Volume

217,270 shs

Average Volume

117,499 shs

Market Capitalization

$826.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.68